Skip to main content
Erschienen in: Supportive Care in Cancer 6/2015

01.06.2015 | Original Article

Risk factors associated with Clostridium difficile infection in adult oncology patients

verfasst von: Analia Rodríguez Garzotto, Antonio Mérida García, Nerea Muñoz Unceta, M. Mar Galera Lopez, M. Ángeles Orellana-Miguel, C. Vanesa Díaz-García, Susana Cortijo-Cascajares, Hernán Cortes-Funes, M. Teresa Agulló-Ortuño

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Clostridium difficile infection (CDI) prevention is particularly important for cancer patients, because diarrhea often results in dose reductions or delays of chemotherapy or radiotherapy. We conducted this study to better ascertain the incidence, susceptibility, and risk factors for CDI in cancer patients receiving chemotherapy at our hospital.

Methods

We performed a retrospective study among adult cancer patients admitted at “12 de Octubre” University Hospital between January 2009 through April 2013 who were diagnosed with diarrhea. Inpatient data were available on hospital medical records. We screened by immunochromatography system detecting glutamate dehydrogenase antigen, and C. difficile toxins A and B. Later, a polymerase chain reaction for detecting toxin B gene was performed.

Results

A total of 225 patients were included in the study, and 39 of them (17.3 %) were diagnosed with CDI. Type of tumor significantly differed between CDI patients, thus relative risk in each type of cancer was calculated after adjusting for age, antibiotic exposure, corticosteroid, and proton-pump inhibitor use. Patients with gastrointestinal tumors were less prone to CDI. Conversely, breast cancer patients have a greater predisposition to CDI. Antibiotic treatment was found to be associated with an increasing risk for CDI in breast cancer patients. Curiously, exposure to proton-pump inhibitors appeared protective in our cohort, except for lung cancer patients. However, we have not been able to find an association between a particular type of chemotherapy and CDI.

Conclusions

We underscore the urgent need for early recognition and diagnosis of CDI in cancer patients. Our findings indicate a probable association between antibiotic use and CDI incidence, at least in certain cancer, such as breast cancer.
Literatur
1.
Zurück zum Zitat Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O’Connor L et al (2013) Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 369:1195–1205. doi:10.1056/NEJMoa1216064 CrossRefPubMed Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O’Connor L et al (2013) Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 369:1195–1205. doi:10.​1056/​NEJMoa1216064 CrossRefPubMed
2.
Zurück zum Zitat Khan A, Raza S, Batul SA, Khan M, Aksoy T, Baig MA, Berger BJ (2012) The evolution of Clostridium difficile infection in cancer patients: epidemiology, pathophysiology, and guidelines for prevention and management. Recent Pat Antiinfect Drug Discov 7:157–170CrossRefPubMed Khan A, Raza S, Batul SA, Khan M, Aksoy T, Baig MA, Berger BJ (2012) The evolution of Clostridium difficile infection in cancer patients: epidemiology, pathophysiology, and guidelines for prevention and management. Recent Pat Antiinfect Drug Discov 7:157–170CrossRefPubMed
6.
Zurück zum Zitat Kim JS, Ward KK, Shah NR, Saenz CC, McHale MT, Plaxe SC (2013) Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics. Support Care Cancer 21:3103–3107. doi:10.1007/s00520-013-1888-2 CrossRefPubMed Kim JS, Ward KK, Shah NR, Saenz CC, McHale MT, Plaxe SC (2013) Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics. Support Care Cancer 21:3103–3107. doi:10.​1007/​s00520-013-1888-2 CrossRefPubMed
8.
Zurück zum Zitat Cornely OA, Miller MA, Fantin B, Mullane K, Kean Y, Gorbach S (2013) Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin. J Clin Oncol 31:2493–2499. doi:10.1200/JCO.2012.45.5899 CrossRefPubMed Cornely OA, Miller MA, Fantin B, Mullane K, Kean Y, Gorbach S (2013) Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin. J Clin Oncol 31:2493–2499. doi:10.​1200/​JCO.​2012.​45.​5899 CrossRefPubMed
10.
Zurück zum Zitat Morotomi N, Fukuda K, Nakano M, Ichihara S, Oono T, Yamazaki T, Kobayashi N, Suzuki T, Tanaka Y, Taniguchi H (2011) Evaluation of intestinal microbiotas of healthy Japanese adults and effect of antibiotics using the 16S ribosomal RNA gene based clone library method. Biol Pharm Bull 34:1011–1020CrossRefPubMed Morotomi N, Fukuda K, Nakano M, Ichihara S, Oono T, Yamazaki T, Kobayashi N, Suzuki T, Tanaka Y, Taniguchi H (2011) Evaluation of intestinal microbiotas of healthy Japanese adults and effect of antibiotics using the 16S ribosomal RNA gene based clone library method. Biol Pharm Bull 34:1011–1020CrossRefPubMed
11.
Zurück zum Zitat Stringer AM, Gibson RJ, Bowen JM, Keefe DM (2009) Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change. Curr Drug Metab 10:79–83CrossRefPubMed Stringer AM, Gibson RJ, Bowen JM, Keefe DM (2009) Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change. Curr Drug Metab 10:79–83CrossRefPubMed
13.
Zurück zum Zitat Raza S, Baig MA, Russell H, Gourdet Y, Berger BJ (2010) Clostridium difficile infection following chemotherapy. Recent Pat Antiinfect Drug Discov 5:1–9CrossRefPubMed Raza S, Baig MA, Russell H, Gourdet Y, Berger BJ (2010) Clostridium difficile infection following chemotherapy. Recent Pat Antiinfect Drug Discov 5:1–9CrossRefPubMed
14.
15.
Zurück zum Zitat Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N et al (2011) Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365:1693–1703. doi:10.1056/NEJMoa1012413 CrossRefPubMed Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N et al (2011) Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365:1693–1703. doi:10.​1056/​NEJMoa1012413 CrossRefPubMed
16.
Zurück zum Zitat Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079–1084. doi:10.1016/S0140-6736(05)67420-X CrossRefPubMed Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079–1084. doi:10.​1016/​S0140-6736(05)67420-X CrossRefPubMed
17.
18.
Zurück zum Zitat Deshpande A, Pant C, Pasupuleti V, Rolston DD, Jain A, Deshpande N, Thota P, Sferra TJ, Hernandez AV (2012) Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Clin Gastroenterol Hepatol 10:225–233. doi:10.1016/j.cgh.2011.09.030 CrossRefPubMed Deshpande A, Pant C, Pasupuleti V, Rolston DD, Jain A, Deshpande N, Thota P, Sferra TJ, Hernandez AV (2012) Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Clin Gastroenterol Hepatol 10:225–233. doi:10.​1016/​j.​cgh.​2011.​09.​030 CrossRefPubMed
21.
22.
Zurück zum Zitat Orellana-Miguel MA, Alcolea-Medina A, Barrado-Blanco L, Rodriguez-Otero J, Chaves-Sanchez F (2013) Algorithm proposal based on the C. Diff Quik Chek Complete ICT device for detecting Clostridium difficile infection. Enferm Infecc Microbiol Clin 31:97–99. doi:10.1016/j.eimc.2012.01.003 CrossRefPubMed Orellana-Miguel MA, Alcolea-Medina A, Barrado-Blanco L, Rodriguez-Otero J, Chaves-Sanchez F (2013) Algorithm proposal based on the C. Diff Quik Chek Complete ICT device for detecting Clostridium difficile infection. Enferm Infecc Microbiol Clin 31:97–99. doi:10.​1016/​j.​eimc.​2012.​01.​003 CrossRefPubMed
25.
Zurück zum Zitat Hwang KE, Hwang YR, Seol CH, Park C, Park SH, Yoon KH, Park DS, Lee MK, Jeong ET, Kim HR (2013) Clostridium difficile infection in lung cancer patients. Jpn J Infect Dis 66:379–382CrossRefPubMed Hwang KE, Hwang YR, Seol CH, Park C, Park SH, Yoon KH, Park DS, Lee MK, Jeong ET, Kim HR (2013) Clostridium difficile infection in lung cancer patients. Jpn J Infect Dis 66:379–382CrossRefPubMed
26.
Zurück zum Zitat Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK (2012) Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 107:1011–1019. doi:10.1038/ajg.2012.108 CrossRefPubMed Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK (2012) Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 107:1011–1019. doi:10.​1038/​ajg.​2012.​108 CrossRefPubMed
27.
30.
Zurück zum Zitat Chopra T, Alangaden GJ, Chandrasekar P (2010) Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther 8:1113–1119. doi:10.1586/eri.10.95 CrossRefPubMed Chopra T, Alangaden GJ, Chandrasekar P (2010) Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther 8:1113–1119. doi:10.​1586/​eri.​10.​95 CrossRefPubMed
31.
Zurück zum Zitat Baier R, Morphis B, Marsella M, Mermel LA (2013) Clostridium difficile surveillance: a multicenter comparison of LabID events and use of standard definitions. Infect Control Hosp Epidemiol 34:653–655. doi:10.1086/670642 CrossRefPubMed Baier R, Morphis B, Marsella M, Mermel LA (2013) Clostridium difficile surveillance: a multicenter comparison of LabID events and use of standard definitions. Infect Control Hosp Epidemiol 34:653–655. doi:10.​1086/​670642 CrossRefPubMed
Metadaten
Titel
Risk factors associated with Clostridium difficile infection in adult oncology patients
verfasst von
Analia Rodríguez Garzotto
Antonio Mérida García
Nerea Muñoz Unceta
M. Mar Galera Lopez
M. Ángeles Orellana-Miguel
C. Vanesa Díaz-García
Susana Cortijo-Cascajares
Hernán Cortes-Funes
M. Teresa Agulló-Ortuño
Publikationsdatum
01.06.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2506-7

Weitere Artikel der Ausgabe 6/2015

Supportive Care in Cancer 6/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.